{"id":"NCT01611090","sponsor":"Janssen Research & Development, LLC","briefTitle":"A Study of Ibrutinib in Combination With Bendamustine and Rituximab in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma","officialTitle":"Randomized, Double-blind, Placebo-controlled Phase 3 Study of Ibrutinib, a Bruton's Tyrosine Kinase (BTK) Inhibitor, in Combination With Bendamustine and Rituximab (BR) in Subjects With Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2012-09-19","primaryCompletion":"2019-01-23","completion":"2019-01-23","firstPosted":"2012-06-04","resultsPosted":"2020-03-03","lastUpdate":"2020-03-03"},"enrollment":578,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"TRIPLE","primaryPurpose":"TREATMENT"},"conditions":["Chronic Lymphocytic Leukemia","Small Lymphocytic Lymphoma"],"interventions":[{"type":"DRUG","name":"Ibrutinib","otherNames":[]},{"type":"DRUG","name":"Bendamustine hydrochloride","otherNames":[]},{"type":"DRUG","name":"Rituximab","otherNames":[]},{"type":"DRUG","name":"Placebo","otherNames":[]}],"arms":[{"label":"Ibrutinib + BR","type":"EXPERIMENTAL"},{"label":"Placebo + BR","type":"PLACEBO_COMPARATOR"}],"summary":"The purpose of this study is to examine the safety and efficacy of Ibrutinib administered in combination with bendamustine and rituximab in patients with relapsed or refractory chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL).","primaryOutcome":{"measure":"Progression-free Survival (PFS)","timeFrame":"Up to 5 years","effectByArm":[{"arm":"Ibrutinib+BR","deltaMin":65.12,"sd":null},{"arm":"Placebo+BR","deltaMin":14.32,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"< 0.0001"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":8,"exclusionCount":15},"locations":{"siteCount":155,"countries":["United States","Argentina","Belgium","Brazil","Canada","Colombia","Czechia","France","Germany","Greece","Israel","Mexico","Poland","Portugal","Russia","South Korea","Spain","Sweden","Turkey (TÃ¼rkiye)","Ukraine","United Kingdom"]},"refs":{"pmids":["40266025","32762271","31044267","28751558","26655421"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":198,"n":287},"commonTop":["Neutropenia","Diarrhoea","Nausea","Anaemia","Thrombocytopenia"]}}